Tag Archive | "Merck & Co"

Merck acquires Cubist Pharmaceuticals for $9.5bn

Tags: , , ,


Merck and Cubist Pharmaceuticals have entered into a definitive agreement under which Merck will acquire Cubist for $102 per share in cash, which represents a 35 percent premium to Cubist’s average stock price for the most recent five trading days. Read the full story

Pfizer and Merck & Co. sign biotech partnering pact

Tags: , , , , ,


Pfizer and Merck & Co announced a clinical trial biotech partnering deal to test Merck’s Investigational Anti-PD-1 Antibody Pembrolizumab and Pfizer’s Crizotinib (XALKORI) in combination for patients with ALK-positive advanced or metastatic non-small cell lung cancer. Read the full story

Ferring and Merck form a pharma partnership with WHO

Tags: , , ,


Merck and Ferring Pharmaceuticals announced their  pharma partnership with the World Health Organization to advance a new, proprietary formulation of carbetocin, used to prevent excessive bleeding (post-partum hemorrhage) in women after childbirth, that is designed to be stable at room temperature, even in hot and tropical climates. Read the full story

Merck and GSK enter into a pharma licensing deal

Tags: , , , ,


Merck enters into a pharma licensing deal with GSK for evaluating combination therapy for renal cell carcinoma. Read the full story

Big pharma, Forest Lab grabs schizophrenia drugs from Merck

Tags: , , , ,


Forest Laboratories, big pharma, announced that is acquiring exclusive rights in the United States for Saphris (asenapine). Read the full story

Merck & Co to follow in the footsteps of its biggest rival, Pfizer

Tags: , , , , ,


Merck & Co considering a break off of their animal-health and consumer product division, which could boost their share hold value by $50 billion. Read the full story

Pharma licensing deals between Merck & Co and Polyplus-transfection

Tags: , , , ,


Polyplus-transfection and Merck & Co, announced a global prior use Pharma licensing deals agreement and extended supply agreement for Polyplus-transfection’s polyethylenimine based transfection reagents. Read the full story